CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-03). The draft was written by AI, the existence of all 4 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2011 · Search date 2026-08-03 · Methodology v0.6

Pressure-cooked parboiled brown rice,
does it really help with Improved HbA1c?

30-Second Summary
D
Evidence Grade D · 28 · Safety caution
Replacing white rice with brown rice did not lower overall HbA1c
Inorganic arsenic in rice varies by source and product, while FDA background sampling found a higher mean in brown rice. Infants should receive varied grains rather than repeated reliance on rice cereal alone.
What the
research shows
The grade is D. In a three-month crossover trial replacing white rice of the same BPT5204 variety with pressure-cooked parboiled brown rice, the full analysis found no between-diet difference in HbA1c, fasting glucose, or insulin. A significant HbA1c result appeared only in the metabolic-syndrome subgroup and does not overturn the overall null result.
What the
ads claim
Retention of bran and germ is a real compositional fact, but it did not produce an overall HbA1c benefit in this trial. The result applies to replacing white rice, not adding brown rice to the existing diet.
*

Useful facts when choosing a product

  • Brown rice retains more bran and germ than white rice; that compositional fact did not translate into improved overall HbA1c here.
  • A review citing FDA sampling reported background mean inorganic arsenic concentrations of 92 ppb in white rice and 154 ppb in brown rice. These are not measurements of the Indian BPT5204 study rice.
  • FDA advises varying infant cereals rather than relying only on rice cereal, including oat, barley, and multigrain options.
  • Funding came from NIH Fogarty International Center grant R03TW008726.
  • Rice has a long record as an East Asian food. No specific classical chapter, volume, or quotation is asserted.
  • Verdict 107 is A with 88 points for isolated oat beta-glucan and cholesterol; verdict 063 is C with 46 points for soy isoflavones and menopausal symptoms; verdict 513 is C with 58 points for soy protein and LDL; verdict 431 is C with 40 points for black-soybean seed-coat extract and eye fatigue. All differ in ingredient or outcome from whole brown rice.
Gap Measurement · Verdict 2011 · D 28
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The peer-reviewed Malik trial was cross-checked against NCT01814735. The 166-person crossover trial had 33% overall attrition; analyzed counts were 120 to 121 per diet period and 112 in adjusted comparisons. The registry was posted in 2013 after a 2010 start and described 150 participants, four months, and a parallel design, unlike the paper's 166 participants, three months, and crossover design.

02

Why this is classified as D (28)

The full-population glycemic outcomes were null, and the missing adjusted confidence interval prevents judging whether a meaningful benefit was excluded. One null trial therefore supports D with 28 points.

Counterpoint. The metabolic-syndrome subgroup finding is a hypothesis for independent replication, not a replacement for the overall result.

Rejudgment record. Cross-check applied — Cross-checked full and subgroup tables, analyzed counts, retrospective registration mismatch, and FDA arsenic background data

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Replacing white rice with pressure-cooked parboiled brown rice improves HbA1cDThe adjusted overall analysis was null; only a subgroup was positive.
Brown rice always contains 154 ppb inorganic arsenicD154 ppb is a background FDA sample mean, not a fixed value for the trial product or all brown rice.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Randomized crossover trial in 166 adults replacing white rice with pressure-cooked parboiled brown rice of the same variety112NIH Fogarty International Center R03TW008726HbA1c, fasting glucose, and insulinOverall HbA1c difference −0.04±0.05 percentage points, P=0.46; glucose and insulin also null; metabolic-syndrome subgroup only −0.18±0.08, P=0.03Peer-reviewed primary report determining the overall result
§

Receipt — 4 References

All 4 cited sources were verified for existence at the original page (as of 2026-08-03).

Malik V, et al. Substituting brown rice for white rice on diabetes risk factors in India: a randomised controlled trial. Br J Nutr. 2019;121:1389-1397.
checked
ClinicalTrials.gov. NCT01814735.
checked
FDA. Arsenic in Rice and Rice Products Risk Assessment.
checked
FDA. What You Can Do to Limit Exposure to Arsenic.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none

Cite this verdict

Pressure-cooked parboiled brown rice x improved HbA1c Evidence Grade D card
[Chamgap] Pressure-cooked parboiled brown rice x improved HbA1c — Evidence Grade D·28. 4 cited sources checked. Source: https://chamgap.com/en/verdicts/blood-sugar/pressure-cooked-parboiled-brown-rice-hba1c/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.